Clinical Trial Update: Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass [NA]

View source ↗

Summary

Clinical trial assessing the effects of exenatide, sitagliptin, or glimepiride on functional beta-cell mass in pre-diabetes and type 2 diabetes, completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pre-diabetes
• Type 2 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)
• Glimepiride (glimepiride)
• Sitagliptin (sitagliptin)

Snippet

Sponsor: University of Pennsylvania | Conditions: Pre-diabetes, Type 2 Diabetes | NA | Status: COMPLETED | Results posted: 2017-12-06